Clinigence reappoints Mark Fawcett to board and as Compensation Committee Chairman

Nutex Health Inc.

Reappointed July 14, 2021; holds office until next annual election.
Fawcett is SVP & Treasurer of Fresenius Medical Care Holdings (NYSE: FMS).
Previously served on Clinigence board Oct 2019–June 2020; replaces resigned director Randall Stern.
Also board member of Apollo Medical Holdings (Nasdaq: AMEH) since January 2016.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Mark Fawcett

Member of the Board of Directors

NUTX · Nutex Health Inc.

Effective: 2021-07-14
Filed: July 22, 2021, 7:59 PM ET

On July 14, 2021, the Board of Directors (the “Board”) of Clinigence Holdings, Inc., (the "Company") reappointed Mark Fawcett as a member of the Board of Directors and Chairman of the Compensation Committee.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Mark Fawcett was appointed as Member of the Board of Directors at Nutex Health Inc..

Action: reappointed
Role: Member of the Board of Directors

Exact text from the filing

On July 14, 2021, the Board of Directors (the “Board”) of Clinigence Holdings, Inc., (the "Company") reappointed Mark Fawcett as a member of the Board of Directors and Chairman of the Compensation Committee.

View on SEC.gov

Nutex Health Inc. filing history →

Source: SEC EDGAR

accession 0001607062-21-000235

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.